Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating substantial results in the control of type 2 diabetes. This synthetic peptide resembles the actions of naturally present GLP-1, a hormone that plays a crucial role in managing blood insulin response. By enhancing GLP-1 receptors in the pancreas, Retasturtide promotes